Literature DB >> 16131642

Feasibility and outcome of HCV treatment in a Canadian federal prison population.

John Farley1, Shawn Vasdev, Benedikt Fischer, Emma Haydon, Jürgen Rehm, Theresa A Farley.   

Abstract

We assessed feasibility and outcome of hepatitis C virus (HCV) treatment in male correctional inmates in British Columbia, Canada. We reviewed the medical charts of 114 treated inmates; 80 had complete data for treatment outcome. Approximately 4 of 5 inmates completed treatment (78.8%); 66.3% achieved sustained virological response. Those who completed treatment, those with injection drug use as a risk factor, and those with genotypes 2 and 3 were significantly more likely to achieve sustained virological response. HCV treatment in correctional inmates is feasible and effective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131642      PMCID: PMC1449428          DOI: 10.2105/AJPH.2004.056150

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

2.  A health care needs assessment of federal inmates in Canada.

Authors: 
Journal:  Can J Public Health       Date:  2004 Mar-Apr

3.  Two-sided confidence intervals for the single proportion: comparison of seven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

Review 4.  Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.

Authors:  M Sherman
Journal:  Can J Gastroenterol       Date:  1997 Jul-Aug       Impact factor: 3.522

5.  Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.

Authors:  Brian P Mulhall; Zobair Younossi
Journal:  J Clin Gastroenterol       Date:  2005-01       Impact factor: 3.062

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention.

Authors:  Prithwish De; Nancy Connor; Françoise Bouchard; Donald Sutherland
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

8.  Prior opiate injection and incarceration history predict injection drug use among inmates.

Authors:  Liviana M Calzavara; Ann N Burchell; Julia Schlossberg; Ted Myers; Michael Escobar; Evelyn Wallace; Carol Major; Carol Strike; Margaret Millson
Journal:  Addiction       Date:  2003-09       Impact factor: 6.526

9.  Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Authors:  T Poynard; P Marcellin; S S Lee; C Niederau; G S Minuk; G Ideo; V Bain; J Heathcote; S Zeuzem; C Trepo; J Albrecht
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  Treatment of chronic hepatitis C in a state correctional facility.

Authors:  Scott A Allen; Anne C Spaulding; Albert M Osei; Lynn E Taylor; Asya M Cabral; Josiah D Rich
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

View more
  19 in total

1.  Survey of US Correctional Institutions for Routine HCV Testing.

Authors:  Curt G Beckwith; Ann E Kurth; Lauri Bazerman; Liza Solomon; Emily Patry; Josiah D Rich; Irene Kuo
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  New opportunities for the management and therapy of hepatitis C in correctional settings.

Authors:  C Kent Martin; Jeffrey E Hostetter; John J Hagan
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

Review 3.  Health status of prisoners in Canada: Narrative review.

Authors:  Fiona Kouyoumdjian; Andrée Schuler; Flora I Matheson; Stephen W Hwang
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

Review 4.  Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.

Authors:  Iain F Brew; Christine Butt; Nat Wright
Journal:  Br J Gen Pract       Date:  2013-12       Impact factor: 5.386

5.  A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.

Authors:  Curt G Beckwith; Ann E Kurth; Lauri B Bazerman; Emily J Patry; Alice Cates; Liem Tran; Amanda Noska; Irene Kuo
Journal:  J Public Health (Oxf)       Date:  2015-03-02       Impact factor: 2.341

6.  Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.

Authors:  K Neukam; J A Mira; I Gilabert; E Claro; M J Vázquez; C Cifuentes; S García-Rey; N Merchante; C Almeida; J Macías; J A Pineda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-06       Impact factor: 3.267

7.  Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C.

Authors:  Kara W Chew; Scott A Allen; Lynn E Taylor; Josiah D Rich; Edward Feller
Journal:  J Clin Gastroenterol       Date:  2009-08       Impact factor: 3.062

Review 8.  Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment.

Authors:  Rosa Zampino; Nicola Coppola; Caterina Sagnelli; Giovanni Di Caprio; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-09-28

9.  Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.

Authors:  Alain H Litwin; Kenneth A Harris; Shadi Nahvi; Philippe J Zamor; Irene J Soloway; Peter L Tenore; Daniel Kaswan; Marc N Gourevitch; Julia H Arnsten
Journal:  J Subst Abuse Treat       Date:  2008-11-28

10.  Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.

Authors:  Duncan Smith-Rohrberg Maru; Robert Douglas Bruce; Sanjay Basu; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.